Elken Healthcare (01789) is now up more than 5%. As of press release, it is up 5.15% to HK$6.13, with a turnover of HK$17.964 million.
The Zhitong Finance App learned that Elken Healthcare (01789) is now up more than 5%. As of press release, it has risen 5.15% to HK$6.13, with a turnover of HK$17.764 million.
According to the news, according to an interface report, we learned from the ongoing procurement site where the centralized procurement agreement for artificial joints organized by the state has expired and that Elken Medical has declared a total of 4 products. In terms of specific prices, the price for the ceramic-ceramic hip product system is 7,946 yuan, the ceramic-polyethylene hip product system is 7041 yuan, the price for the alloy-polyethylene hip product system is 5989 yuan, and the price for the knee product system is 5,323 yuan.
Tianfeng Securities pointed out that the tender will soon be opened for the renewal of centralized procurement of artificial joints. Artificial joints are the second high-consumption variety purchased in China. The idea of renewing contracts and increasing prices continues the purchase of stents. We believe that there is still plenty of room to improve the penetration rate of joints. For the volume of off-standard surgeries, leading companies are expected to gain more share with excellent R&D and sales capabilities and perfect supply capacity